Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record now shows Results Posted on 2026-04-29 with updated outcomes (PFS, ORR, OS, adverse events) and provides the Informed Consent Form PDF and Study Protocol/SAP; prior entries like Results Submitted and shorter timeframes have been replaced with the new posted-results status and extended timeframes.
    Difference
    1%
    Check dated 2026-05-04T01:31:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the underlying study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:29:31.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision changed from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:49:55.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:09:29.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-03-07T12:47:11.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive changes to page content or study details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:27.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.